Cambrex Corp
Change company Symbol lookup
Select an option...
CBM Cambrex Corp
CHK Chesapeake Energy Corp
TMMI TMM Inc
TCRD THL Credit Inc
TROW T. Rowe Price Group Inc
OASM Oasmia Pharmaceutical AB
TEHG Technovative Group Inc
LBRDK Liberty Broadband Corp
ITIC Investors Title Co
DDD 3D Systems Corp
Go

Health Care : Life Sciences Tools & Services | Small Cap GrowthCompany profile

Cambrex Corporation (Cambrex) is a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Company's customers include generic drug companies and companies that discover and commercialize small molecule human therapeutics using organic chemistry. Its business consists of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The Company's products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates and, to a lesser extent, other fine chemicals. Cambrex has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment.

Closing Price
$36.53
Day's Change
0.03 (0.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
38.37
Day's Low
35.43
Volume
(Average)
Volume:
792,215
10-day average volume:
838,614
792,215
Latest Earnings Beat Consensus (Q4 ending 12/2015)Next Earnings Announcement
Q4
Announced February 9, 2016
$1.01Q4 Consensus
of 4 analysts
$0.83Difference from
consensus
17.82%
Q1 Earnings
will announce
(Unconfirmed) April 28, 2016

Quarterly Earnings History and Estimates

Show high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.

Display:

UpdateCancel

CBM's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Information provided by Copyright © 2016. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.